Skip to content

Usefulness of meditation in psoriasis

Effectiveness of Meditation in the treatment of moderate to severe psoriasis: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/047862
Enrollment
50
Registered
2022-12-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: Heartfulness meditation and standard treatment (Oral methotrexate): 1. Methotrexate standard weekly dose for psoriasis will be given. Dose ranging from 7.5mg/week to 25mg/week 2. Heartf

Sponsors

AIIMS Mangalagiri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Consecutive consenting patients of both genders aged 18-60 years, attending dermatology OPD of AIIMS Mangalagiri diagnosed with moderate to severe psoriasis • Definition of moderate to severe psoriasis is (BSA > 10 or PASI >10) and DLQI > 10. Special clinical situations may change mild psoriasis to moderate to severe including involvement of visible areas or severe nail involvement.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women 2. Pre-existing psychiatric illness 3. Pre-existing illnesses like hepatic and renal disease, connective tissue diseases, and malignancies 4. Disease onset within the last 3 months 5. Patients who are practicing yoga/meditation regularly in the past 3 months

Design outcomes

Primary

MeasureTime frame
Time taken to achieve PASI 75 score.(75% reduction of disease severity from baseline)Timepoint: After 4 months of intervention

Secondary

MeasureTime frame
1. Effectiveness of the meditation on the changes in the serum levels of interleukin 6, and serum cortisol in patients with psoriasis 2. Effectiveness of the intervention on the changes in the stress scores and sleep scores.Timepoint: After 4 months of intervention

Countries

India

Contacts

Public ContactPrabhakaran N

AIIMS Mangalagiri

drprabha@aiimsmangalagiri.edu.in7868023215

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026